Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EMvision Medical Devices.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: We’re not angry. Just… disappointed after a midweek sag
Health & Biotech
Curvebeam’s “weight-bearing CT scanner” to gain more traction after FDA clearance
Health & Biotech
ASX Health Stocks: Focus on retina-disease drug study draws eyes
Health & Biotech
ASX Health Stocks: Proteomics to start selling in France; Recce to start clinical trials
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Rare earths hit launches 300pc small cap moon shot, as ASX benchmark beards its bears
Health & Biotech
ASX Health Stocks: EMV’s AI algo shows promise, and Telix submits new FDA application
News
Market Highlights: ASX to rebound after US survey; and 5 ASX small caps to watch today
Health & Biotech
ASX Health Stocks: EMV gets strategic US$15m investment from NYSE-listed giant
News
Market Highlights: New record in sight for Bitcoin, and 5 ASX small caps to watch on Thursday
Health & Biotech
Check Up: Introducing the Brain Atlas, the largest map of the human brain. And recent ASX biotech winners
Health & Biotech
ASX Health Stocks: EMvision calls its AI brain scanner ’emu’
Health & Biotech
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
Health & Biotech
ASX Health Stocks: Recce moves forward in Phase 1/2 study; EMV unveils Gen 2 helmet scanner for ambulance
Health & Biotech
ASX Health Stocks: Paradigm to seek TGA nod after successful trial; EMVision uses AI simulation
News
Market Highlights: Gold, oil and defence stocks advance on Wall Street; and 5 ASX small caps to watch today
Health & Biotech
